Lv1
40 积分 2024-09-11 加入
RNA Interference With Zilebesiran for Mild to Moderate Hypertension
5个月前
已完结
Add-On Treatment With Zilebesiran for Inadequately Controlled Hypertension
5个月前
已完结
Lowering systolic blood pressure to less than 120 mm Hg versus less than 140 mm Hg in patients with high cardiovascular risk with and without diabetes or previous stroke: an open-label, blinded-outcome, randomised trial
5个月前
已完结
Blood pressure-lowering efficacy of antihypertensive drugs and their combinations: a systematic review and meta-analysis of randomised, double-blind, placebo-controlled trials
5个月前
已完结
Prevalence of dysphagia in China: an epidemiology survey of 6102 participants
10个月前
已完结
Advancement in the Formulation and development of orally disintegrating tablets: innovation, challenges, and future perspective
10个月前
已关闭
坎地氢噻降压及靶器官保护应用中国专家共识
11个月前
已关闭
Efficacy and safety of bisoprolol 5 mg plus amlodipine 5 mg in patients with hypertension uncontrolled on monotherapy with 5 mg of amlodipine, a phase III multicenter, randomized, double-blind, placebo-controlled clinical trial – the AMCOR study
1年前
已完结
Renal outcomes with different fixed-dose combination therapies in patients with hypertension at high risk for cardiovascular events (ACCOMPLISH): a prespecified secondary analysis of a randomised controlled trial
1年前
已完结
盐酸阿罗洛尔治疗原发性高血压的临床综合评价
1年前
已完结
皖公网安备34019202002308
